These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An in vivo comparison of CPD and CPDA-2 preserved platelet concentrates after an 8-hour preprocess hold of whole blood. Bolin RB, Cheney BA, Smith DJ, Gildengorin V, Shigekawa R. Transfusion; 1982; 22(6):491-5. PubMed ID: 7147328 [Abstract] [Full Text] [Related]
6. In vitro quality and hemostatic function of cold-stored CPDA-1 whole blood after repeated transient exposure to 28°C storage temperature. Sivertsen J, Hervig T, Strandenes G, Kristoffersen EK, Braathen H, Apelseth TO. Transfusion; 2022 Aug; 62 Suppl 1(Suppl 1):S105-S113. PubMed ID: 35748681 [Abstract] [Full Text] [Related]
8. Optimizing whole blood storage: hemostatic function of 35-day stored product in CPD, CP2D, and CPDA-1 anticoagulants. Meledeo MA, Peltier GC, McIntosh CS, Bynum JA, Cap AP. Transfusion; 2019 Apr; 59(S2):1549-1559. PubMed ID: 30980756 [Abstract] [Full Text] [Related]
9. Effects of four additive solutions on canine leukoreduced red cell concentrate quality during storage. Lacerda LA, Hlavac NR, Terra SR, Back FP, Jane Wardrop K, González FH. Vet Clin Pathol; 2014 Sep; 43(3):362-70. PubMed ID: 25135622 [Abstract] [Full Text] [Related]
14. Hemostatic potential of cold-stored non-leukoreduced whole blood over time: An assessment of platelet function and thrombin generation for optimal shelf life. Assen S, Cardenas J, George M, Wang YW, Wade CE, Meyer D, Cotton BA. J Trauma Acute Care Surg; 2020 Sep; 89(3):429-434. PubMed ID: 32467473 [Abstract] [Full Text] [Related]
15. Assessment of changes in plasma hemoglobin and potassium levels in red cell units during processing and storage. Saini N, Basu S, Kaur R, Kaur J. Transfus Apher Sci; 2015 Jun; 52(3):319-25. PubMed ID: 25665725 [Abstract] [Full Text] [Related]
16. In vivo viability of red blood cells stored in CPDA-2. Sohmer PR, Moore GL, Beutler E, Peck CC. Transfusion; 1982 Jun; 22(6):479-84. PubMed ID: 7147326 [Abstract] [Full Text] [Related]
17. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma. Wiltshire M, Cardigan R, Thomas S. Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977 [Abstract] [Full Text] [Related]
18. Hemostatic properties of cold-stored whole blood leukoreduced using a platelet-sparing versus a non-platelet-sparing filter. Haddaway K, Bloch EM, Tobian AAR, Frank SM, Sikorski R, Cho BC, Zheng G, Jani J, Lokhandwala PM, Lawrence CE, Blagg L, Ness PM, Kickler TS, Gehrie EA. Transfusion; 2019 May; 59(5):1809-1817. PubMed ID: 30741432 [Abstract] [Full Text] [Related]
19. Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35-day cold-storage regardless of leukoreduction timing. Schubert P, Culibrk B, Bhakta V, Closas T, Sheffield WP, Devine DV, McTaggart K. Transfusion; 2022 Aug; 62 Suppl 1():S98-S104. PubMed ID: 35748674 [Abstract] [Full Text] [Related]
20. Effect of leukoreduction and pathogen reduction on the hemostatic function of whole blood. Thomas KA, Shea SM, Yazer MH, Spinella PC. Transfusion; 2019 Apr; 59(S2):1539-1548. PubMed ID: 30980757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]